ReviewChemistry, an Asian journal2026
Early Transition Metal-Based Antitumor Complexes.
Review in Chemistry, an Asian journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Capillary Electrophoresis and Atomic Absorption Spectrometry-A Rare Yet Valuable Liaison, Also from a Pharmaceutical Perspective.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Cancer is a major disease that seriously threatens human health worldwide. The development of highly effective and low toxicity anticancer drugs has always been a research hotspot. Transition metal complexes, as antitumor drugs, offer multiple advantages, including the synergistic effect of targeting multiple sites, which reduces drug resistance, strong structural adjustability for optimizing the efficacy of the medicine, unique photodynamic/photothermal therapy capabilities, and the ability to integrate diagnosis and treatment. Early transition metals refer to the d-block metal elements from Group IIIB to Group VIIB in the periodic table. In recent years, antitumor complexes of early transition metals have received extensive attention due to their unique mechanisms of action and potential therapeutic effects. In this review, we summarize the latest advancements in the anticancer effects of metal complexes of Ti, V, Cr, Mn, Mo, Tc, and Re, which represent a new type of anticancer drug with multiple mechanisms, and are expected to provide more effective solutions for precise tumor treatment. With the deepening of research and the development of technology, early transition metal-based drugs may play a more important role in precision medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.